Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2024

Jun 11, 2024

3091_iss_2024-06-11_54a1ded8-415e-40d4-8717-2d62d8a871a4.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Nordnet AB (publ)

Instrument

Instrument Aktie SE0009414576
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Sell
Date 10/06/2024
Limit for number of shares 5 %
After the transaction
Quantity
Shares 10,720,323
Directly held voting rights 0
Indirectly held voting rights 10,720,323
Percentage
Directly held shares 4.98188 %
Directly held voting rights 0 %
Indirectly held voting rights 5.0701 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.0701 % 10,720,323
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.0701 % 10,720,323
Chain
of
controlling
companies
Voting rights % Voting rights Company
10,403,564 4.92029
Nordnet Pensionsförsäkring AB
316,759
0.1498
Nordnet Livsforsikring AS
Group
total
holdings
Voting rights
10,720,323
Percentage of voting rights 5.0701
Published
11/06/2024 14:06
Contact
Name
Felix Mandoki
Phone
+46766110734 Email [email protected]
*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25